Viewing Study NCT02685657


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2026-01-05 @ 5:15 PM
Study NCT ID: NCT02685657
Status: UNKNOWN
Last Update Posted: 2016-02-22
First Post: 2016-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
Sponsor: Russian Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module